Status:
COMPLETED
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?
Lead Sponsor:
Kochi University
Conditions:
Pancreatic Cancer Metastatic
Eligibility:
All Genders
Brief Summary
The recurrent pancreatic cancer (Rec-PC) after radical surgery is sometimes eligible to clinical trial of chemotherapy for unresectable pancreatic cancer. However, the difference between Rec-PC and pr...
Eligibility Criteria
Inclusion
- unresectable pancreatic cancer
Exclusion
- Patients expected to survive for less than three months
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT06921252
Start Date
January 1 2010
End Date
March 1 2025
Last Update
April 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.